4.4 Article

Craving of Prescription Opioids in Patients With Chronic Pain: A Longitudinal Outcomes Trial

期刊

JOURNAL OF PAIN
卷 13, 期 2, 页码 146-154

出版社

CHURCHILL LIVINGSTONE
DOI: 10.1016/j.jpain.2011.10.010

关键词

Craving; noncancer pain; opioid therapy; opioid misuse; substance abuse

资金

  1. National Institute of Drug Abuse (NIDA) of the National Institutes of Health [K23 DA020682]
  2. Arthritis Foundation
  3. Endo Pharmaceuticals, Chadds Ford, PA
  4. NIDA [R21 DA024298, K24 DA019855, K24 DA022288]

向作者/读者索取更多资源

Little is known about whether patients with chronic pain treated with opioids experience craving for their medications, whether contextual cues may influence craving, or if there is a relationship between craving and medication compliance. We hypothesized that craving for prescription opioids would be significantly correlated with the urge for more medication, preoccupation with the next dose, and current mood symptoms. We studied craving in 62 patients with chronic pain who were at low or high risk for opioid misuse, while they were enrolled in an RCT to improve prescription opioid medication compliance. Using electronic diaries, patients completed ratings of craving at monthly clinic visits and daily during a 14-day take-home period. Both groups consistently endorsed craving, whose levels were highly correlated (P < .001) with urge, preoccupation, and mood. The intervention to improve opioid compliance in the high-risk group was significantly associated with a rate of decrease in craving over time in comparison to a high-risk control group (P < .05). These findings indicate that craving is a potentially important psychological construct in pain patients prescribed opioids, regardless of their level of risk to misuse opioids. Targeting craving may be an important intervention to decrease misuse and improve prescription opioid compliance. Perspective: Patients with noncancer pain can crave their prescription opioids, regardless of their risk for opioid misuse. We found craving to be highly correlated with the urge to take more medication, fluctuations in mood, and preoccupation with the next dose, and to diminish with a behavioral intervention to improve opioid compliance. (C) 2012 by the American Pain Society

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据